ArticleAmerican journal of translational research2021

Comparison of pyrotinib or lapatinib with chemotherapy for patients with HER2 positive breast cancer after first-line treatment failure: a retrospective study.

Huihui Yang et al.PubMed ↗Full text ↗

No numbers read from the abstract.